<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To analyze the causes of failure in conventional treatment to refractory <z:hpo ids='HP_0002020'>gastroesophageal reflux diseases</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) patients, 16 refractory <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients (group R) and 16 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> primarily diagnosed (group P) were studied </plain></SENT>
<SENT sid="1" pm="."><plain>Endoscopy, pathologic examination and <z:chebi fb="32" ids="36927">14C</z:chebi> <z:chebi fb="20" ids="16199">urea</z:chebi> breath test were conducted in every patient </plain></SENT>
<SENT sid="2" pm="."><plain>24 h ambulatory pH and <z:chebi fb="0" ids="16990">bilirubin</z:chebi> monitoring were performed with Digitrapper MK III and Synetics Bilitec 2000 </plain></SENT>
<SENT sid="3" pm="."><plain>It was found that <z:hpo ids='HP_0100633'>esophagitis</z:hpo> in group R was more severe than in group P </plain></SENT>
<SENT sid="4" pm="."><plain>The rate of <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> in group R was significantly lower than in group P </plain></SENT>
<SENT sid="5" pm="."><plain>Fraction time pH below 4.00 was not longer while the <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> represented by fraction time abs above 0.14 was greater for patients in the group R as compared with those in the group P </plain></SENT>
<SENT sid="6" pm="."><plain>The mixed refluxes and pure bile refluxes between the two groups had significant difference </plain></SENT>
<SENT sid="7" pm="."><plain>The reflux episodes in the group R mainly occurred during nights </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicated that severe <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, especially <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with complications makes it difficult to control <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Severe duodenogastroesophageal refluxes (DGER) are often accompanied by refractory <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Mixed refluxes aggravate the esophageal injuries </plain></SENT>
<SENT sid="11" pm="."><plain>Pure bile refluxes and nocturnal refluxes may cause failure of administration of <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPI</z:chebi>) in the morning </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> and acid refluxes may not be the direct cause of refractoriness </plain></SENT>
<SENT sid="13" pm="."><plain>Individual refractory <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patient without abnormal results on pH or <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> recently should be diagnosed again </plain></SENT>
</text></document>